About
Beacon Therapeutics is a biotechnology firm in the clinical stage focused on preserving and enhancing vision for individuals affected by both uncommon and widespread eye disorders. The organization is leveraging the revolutionary potential of gene therapy to achieve significant results for serious eye conditions. Currently, Beacon's pipeline is aimed at severe retinal diseases that cause blindness, including X-linked retinitis pigmentosa (XLRP) and geographic atrophy.
Team & affiliation
Founders: [object Object].
Region context
Beacon Therapeutics is one of 3 Biotechnology companies we track in Gainesville / North Central, based in Alachua — about 20% of the region's 15 startups.
Gainesville — a UF-anchored research corridor strong in biotech, medtech, and university spinouts.
See the full Gainesville / North Central ecosystem →